KPIs & Operating Metrics(New)

Adult Nutritionals Revenue By Region Adult Nutritionals Revenue By Region Annual Assets By Segment Breakdown Of Assets Capital Expenditure Core Laboratory Revenue By Region Core Laboratory Revenue By Region Annual Covid Test Diagnostic Revenue By Region Covid Test Diagnostic Revenue By Region Annual Covid Test Revenue By Category Covid Test Revenue By Category Annual Diabetes Care Revenue By Region Diabetes Care Revenue By Region Annual Diagnostics Revenue By Tests Diagnostics Revenue By Tests Annual Diagonostics Revenue By Category Diagonostics Revenue By Category Annual Electrophysiology Revenue By Region Electrophysiology Revenue By Region Annual Employee Ststistics Established Pharmaceutical Revenue By Category Established Pharmaceutical Revenue By Category Annual Gross Margin Gross Margin%Heart Failure Revenue By Region Heart Failure Revenue By Region Annual Income Before Income Tax By Region International Revenue By Geographic Area Manufacturing Facilities Count By Segment Medical Devices Revenue By Category Medical Devices Revenue By Category Annual Molecular Revenue By Region Molecular Revenue By Region Annual Neuromodulation Revenue By Region Neuromodulation Revenue By Region Annual Non Gaap Profitability Non Gaap Profitability %Non Gaap Profitability Annual Non Gaap Profitability Annual %Nutritionals Revenue By Category Nutritionals Revenue By Category Annual Operating Earnings By Segment Operating Earnings By Segment Annual Operating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX Segregation Pediatric Nutritionals Revenue By Region Pediatric Nutritionals Revenue By Region Annual Point Of Care Revenue By Region Point Of Care Revenue By Region Annual Property, Plant And Equipment, Net Breakdown Rapid Diagnostics Revenue By Region Rapid Diagnostics Revenue By Region Annual Remaining Performance Obligations Remaining Performance Obligations Annual Revenue By Geography Revenue By Geography %Revenue By Geography Annual Revenue By Geography Annual %Revenue By Segment Revenue By Segment %Revenue By Segment Annual Revenue By Segment Annual %Rhythm Management Revenue By Region Rhythm Management Revenue By Region Annual Structural Heart Revenue By Region Structural Heart Revenue By Region Annual Vascular Revenue By Region Vascular Revenue By Region Annual

Balance Sheet

Daily Values

Growth Metrics

Others

Abbott Laboratories (ABT) Gross Margin (2016 - 2025)

Historic Gross Margin for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 55.36%.

Abbott Laboratories' Gross Margin fell 4600.0% to 55.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 55.89%, marking a year-over-year increase of 3400.0%. This contributed to the annual value of 55.41% for FY2024, which is 2200.0% up from last year.
Per Abbott Laboratories' latest filing, its Gross Margin stood at 55.36% for Q3 2025, which was down 4600.0% from 56.44% recorded in Q2 2025.
Abbott Laboratories' Gross Margin's 5-year high stood at 59.53% during Q3 2021, with a 5-year trough of 51.61% in Q2 2021.
Moreover, its 5-year median value for Gross Margin was 55.57% (2023), whereas its average is 55.94%.
The largest annual percentage gain for Abbott Laboratories' Gross Margin in the last 5 years was 45700bps (2022), contrasted with its biggest fall of -39900bps (2022).
Quarter analysis of 5 years shows Abbott Laboratories' Gross Margin stood at 58.44% in 2021, then dropped by -7bps to 54.48% in 2022, then rose by 2bps to 55.51% in 2023, then dropped by -1bps to 54.97% in 2024, then rose by 1bps to 55.36% in 2025.
Its last three reported values are 55.36% in Q3 2025, 56.44% for Q2 2025, and 56.86% during Q1 2025.